Want to buy for someone else? You can purchase a token at check out.
This course is free with a membership upgrade!
Upgrade to a Standard membership and gain access to 1,000+ CE and professional development courses.
Overview
The goal of this course is to inform the healthcare team in the acute care setting of the most current information about VTE pharmacological treatment.Goals and Learning Outcomes
When it comes to the treatment of venous thromboembolism (VTE), every member of the healthcare team plays a critical role in ensuring patient safety. Subtherapeutic treatment can lead to blood clots, and the administration of excess dosing may lead to complications of hemorrhage. Keeping up to date with current VTE pharmacotherapy can aid in patients receiving the most optimal treatment for their condition and with providing patient education.
The goal of this course is to inform the healthcare team in the acute care setting of the most current information about VTE pharmacological treatment.
- Recall the American College of Chest Physicians (CHEST) guidelines, duration, and complications of medications used to treat deep vein thrombosis (DVT) and superficial vein thrombosis (SVT).
- Recognize the classes of drugs used to treat DVT and the role of thrombolytics in the management of DVT.
- List the adverse effects of heparin, low-molecular-weight heparin (LMWH), and vitamin K antagonists (VKAs).
Course Details
Course Originally Released on : 8/1/2023
Course Expiration Date : 12/31/2026
REL-ACU-0-PTDVT
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.